Metraipolis › archive › dc_2ddbbe91cb36

Immunomodulatory peptide-drug conjugate MEL-dKLA suppresses progression of prostate cancer by eliminating M2-like tumor-associated macrophages — Europe PMC PMID:41019043

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41019043
DOI: 10.3389/fimmu.2025.1652166
License (as archived): solo-consultazione
Archived: 2026-11-10T00:18:51.199Z
SHA-256 of the archived text: a9f13ae2dbdaf2ad270f5efd62e0bb76faffcc341c35f58551fb051e2cf89090
Stable URL of this page: https://metraipolis.com/documento/dc_2ddbbe91cb36

How to cite

Immunomodulatory peptide-drug conjugate MEL-dKLA suppresses progression of prostate cancer by eliminating M2-like tumor-associated macrophages — Europe PMC PMID:41019043 — Europe PMC (en), https://europepmc.org/article/MED/41019043 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ddbbe91cb36 (Metraipolis archive dc_2ddbbe91cb36, sha256 a9f13ae2dbdaf2ad270f5efd62e0bb76faffcc341c35f58551fb051e2cf89090)

BibTeX

@misc{dc2ddbbe91cb36,
  title = {Immunomodulatory peptide-drug conjugate MEL-dKLA suppresses progression of prostate cancer by eliminating M2-like tumor-associated macrophages — Europe PMC PMID:41019043},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41019043},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ddbbe91cb36; sha256 a9f13ae2dbdaf2ad270f5efd62e0bb76faffcc341c35f58551fb051e2cf89090},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41019043. Agents can read the archived copy with the MCP tool read_document.